Ken Griffin's position in Abbott Laboratories is currently worth $179 Million. That's 0.18% of their equity portfolio (110th largest holding). The first Abbott Laboratories trade was made in Q2 2013. Since then Ken Griffin bought shares 52 more times and sold shares on 47 occasions. The stake costed the investor $136 Million, netting the investor a gain of 31% so far.